Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | MME | P08473 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
| ▸ | CPA1 | P15085 | 1/20 | 0.31 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3416543 | 1.00 | SLC7A5 (0.40) | SLC7A5TP53RAB9AMMEACE | |
| SCHEMBL10408938 | 1.00 | SLC7A5 (0.40) | SLC7A5TP53RAB9AMMEACE | |
| SCHEMBL6756485 | 0.81 | SLC7A5 (0.37) | SLC7A5TP53 | |
| SCHEMBL27881872 | 0.81 | ALDH1A1 (0.39) | SLC7A5TP53GABRR1CA2CA1 | |
| SCHEMBL6756484 | 0.81 | SLC7A5 (0.37) | SLC7A5TP53 | |
| Hydrochloric Acid SCHEMBL28618965 | 0.79 | SLC7A5 (0.36) | SLC7A5TP53 | |
| Hydrochloric Acid SCHEMBL8194549 | 0.79 | SLC7A5 (0.36) | SLC7A5TP53 | |
| SCHEMBL542297 | 0.77 | ALDH1A1 (0.37) | SLC7A5TP53RAB9AMMEACE | |
| SCHEMBL542299 | 0.77 | ALDH1A1 (0.37) | SLC7A5TP53RAB9AMMEACE | |
| SCHEMBL10869084 | 0.76 | CYP1A2 (0.39) | CA2CA1TSHRNFKB1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117045851-A | Antibacterial liquid spray dressing | 上海医妃医药科技有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-120152745-A | Compounds and their use for detecting diseases in exhaled breath of a subject | 奥斯通医疗有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-118742328-A | Peptide linker comprising two or more payloads | 阿拉里斯生物技术股份公司 | 2024-10-01 | — | — | CN | disclosed |
| US-20240082417-A1 | PROTEIN-POLYMER DRUG CONJUGATES | ASANA BIOSCIENCES, LLC | 2024-03-14 | — | — | US | disclosed |
| CN-117045851-A | Antibacterial liquid spray dressing | 上海医妃医药科技有限公司 | 2023-11-14 | — | — | CN | disclosed |
| CN-116801910-A | Means and methods for producing antibody-linker conjugates | 阿拉里斯生物技术股份公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-116406302-A | Method of transglutaminase conjugation with amino acid based linkers | 阿拉里斯生物技术股份公司 | 2023-07-07 | — | — | CN | disclosed |
| US-20230183326-A1 | PROTEIN-POLYMER-DRUG CONJUGATES | ASANA BIOSCIENCES, LLC | 2023-06-15 | — | — | US | disclosed |
| US-11434278-B2 | Protein-polymer-drug conjugates | ASANA BIOSCIENCES, LLC (US) | 2022-09-06 | — | — | US | disclosed |
| CN-108012545-B | Eukaryotic expression vectors comprising regulatory elements of the globin gene cluster | 葛莱高托普有限公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-105813655-B | Protein-polymer-drug conjugates | 阿萨纳生物科技有限责任公司 | 2022-03-15 | — | — | CN | disclosed |
| US-9765087-B2 | Benzimidazole derivatives | ENANTA PHARMACEUTICALS, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| US-20140341851-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2014-11-20 | — | — | US | disclosed |
| EP-2265283-A1 | AURISTATIN DRUG LINKER CONJUGATES | Seattle Genetics, Inc. (US) | 2010-12-29 | — | — | EP | disclosed |
| WO-2009117531-A1 | AURISTATIN DRUG LINKER CONJUGATES | SEATTLE GENETICS, INC. (US) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009065181-A1 | NANOSTRUCTURES SUITABLE FOR DELIVERY OF AGENTS | APOLLO LIFE SCIENCES LIMITED (AU) | 2009-05-28 | — | — | WO | disclosed |
| WO-2007131286-A1 | NANOSTRUCTURES SUITABLE FOR DELIVERY OF AGENTS | APOLLO LIFE SCIENCES LIMITED (AU) | 2007-11-22 | — | — | WO | disclosed |
| CN-1865228-A | N alpha-Boc-N beta-Cbz-L-2,3 diaminopropionic acid derivative synthesis method | UNIV WUHAN (CN) | 2006-11-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183326-A1 | PROTEIN-POLYMER-DRUG CONJUGATES | PBRM1, STAMBP, TSPO | SLC7A5 2258/4885TP53 2024/4885RAB9A 1410/4885 |
| US-11434278-B2 | Protein-polymer-drug conjugates | PBRM1, STAMBP, TSPO | SLC7A5 2258/4885TP53 2024/4885RAB9A 1410/4885 |
| US-20240082417-A1 | PROTEIN-POLYMER DRUG CONJUGATES | PBRM1, STAMBP, TSPO | SLC7A5 2246/4885TP53 1832/4885RAB9A 1383/4885 |
| US-20140341851-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | EIF2AK2, ZC3HAV1, HAVCR2 | SLC7A5 1560/4885TP53 1313/4885RAB9A 3679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.